Carbon Biosciences
1 follower
Carbon Biosciences is expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues, carry a larger cargo, with minimal neutralizing immunity and the potential to re-dose. Fo... Read more
Org chart
Joel Schneider
President & CEO
Joel Schneider
Collapse
Robert M. Kotin
Founder, Chief Technology Advisor & BOD
Marc Abrams
Chief Scientific Officer
Amy Lurier
Sr. Vice President, Talent & People
Jeff Moffit
VP & Head of Nonclinical Development
Josh Merritt
VP, Manufacturing & Process Development
Sebastian Aguirre
VP, Platform Development
Linda Bruett
Vice President Program Management
Beckett Hart
Head Of Corporate Development And Strategy
Jeff Moffit, PhD, DABT
Vice President, Head of Nonclinical Development
Jianming Qiu
Co-Founder & Advisor
Yoshi Hashimoto
Director Of Novel Vector Development, Platform Development
Sebastian Aguirre Kozlouski, Ph.D.
Co-Founder, Vice President, Head of Platform Development
Steve Dipalma
Chief Financial Officer
